1-171783800-C-T
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2
The NM_015935.5(METTL13):c.214C>T(p.Arg72Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015935.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
METTL13 | NM_015935.5 | c.214C>T | p.Arg72Trp | missense_variant | Exon 2 of 8 | ENST00000361735.4 | NP_057019.3 | |
METTL13 | NM_014955.3 | c.-45C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 8 | NP_055770.1 | |||
METTL13 | NM_001007239.2 | c.214C>T | p.Arg72Trp | missense_variant | Exon 2 of 8 | NP_001007240.1 | ||
METTL13 | NM_014955.3 | c.-45C>T | 5_prime_UTR_variant | Exon 2 of 8 | NP_055770.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251364 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461788Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727194 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74278 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.214C>T (p.R72W) alteration is located in exon 2 (coding exon 2) of the METTL13 gene. This alteration results from a C to T substitution at nucleotide position 214, causing the arginine (R) at amino acid position 72 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at